Thomas G Neil, Schooling C Mary, McGhee Sarah M, Ho Sai-Yin, Cheung Bernard M Y, Wat Nelson M S, Janus Edward D, Lam Karen S L, Lam Tai Hing
Department of Community Medicine, The University of Hong Kong, Hong Kong, China.
Clin Endocrinol (Oxf). 2007 May;66(5):666-71. doi: 10.1111/j.1365-2265.2007.02798.x. Epub 2007 Mar 23.
The metabolic syndrome has been associated with increased mortality in some Caucasian populations, but data in Asian populations are not available. We present data describing the association of the metabolic syndrome with mortality.
The impact of the US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) metabolic syndrome guidelines definition (using Asian central obesity criteria) on mortality was examined using Cox regression analyses in a population-based cohort (n = 2863) of Chinese subjects.
The cohort was followed up for a mean duration of 8.45 years, a total of 24 101 person-years, with 89 deaths (33.7% of vascular origin). Compared to those without any component of the metabolic syndrome, following adjustment for age, socioeconomic status and a range of lifestyle habits, those with the metabolic syndrome had increased risk of both all-cause [hazard ratio (HR) 2.02, 95% confidence interval (CI) 1.02-4.00, P for trend = 0.037] and vascular disease (HR 6.39, 95% CI 1.40-29.2, P < 0.05, P for trend = 0.002) mortality. When those with 0-2 components were compared to those with the metabolic syndrome, the HRs were 1.49 (95% CI 0.95-2.33, P = 0.084) and 3.36 (95% CI 1.57-7.19, P = 0.002), respectively.
This study shows that the metabolic syndrome is associated with increased mortality risk in an Asian population. The high prevalence of the metabolic syndrome, particularly in the elderly, forewarns of a rapidly increasing problem in mainland China, and other Asian populations, which could have overwhelming public health ramifications.
代谢综合征与部分白种人群死亡率增加有关,但亚洲人群的数据尚不可得。我们提供了描述代谢综合征与死亡率之间关联的数据。
采用Cox回归分析,在一个基于人群的中国受试者队列(n = 2863)中,研究美国国家胆固醇教育计划成人治疗组第三次报告(NCEP ATP III)代谢综合征指南定义(采用亚洲中心性肥胖标准)对死亡率的影响。
该队列平均随访8.45年,总计24101人年,有89例死亡(33.7%源于血管疾病)。与无代谢综合征任何组分者相比,在对年龄、社会经济状况和一系列生活习惯进行调整后,患有代谢综合征者全因死亡[风险比(HR)2.02,95%置信区间(CI)1.02 - 4.00,趋势P值 = 0.037]和血管疾病死亡(HR 6.39,95% CI 1.40 - 29.2,P < 0.05,趋势P值 = 0.002)风险均增加。将有0 - 2个组分者与患有代谢综合征者相比,HR分别为1.49(95% CI 0.95 - 2.33,P = 0.084)和3.36(95% CI 1.57 - 7.19,P = 0.002)。
本研究表明,代谢综合征与亚洲人群死亡率风险增加有关。代谢综合征高患病率,尤其是在老年人中,预示着中国大陆和其他亚洲人群中这一问题将迅速加剧,可能产生巨大的公共卫生影响。